LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives $95.25 Consensus Target Price from Brokerages
Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the nine brokerages that are presently covering the stock, MarketBeat.com reports. Four investment analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy […]
Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the nine brokerages that are presently covering the stock, MarketBeat.com reports. Four investment analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy […]
